Diminished Reactive Hematopoiesis and Cardiac Inflammation in a Mouse Model of Recurrent Myocardial Infarction.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
03 03 2020
Historique:
received: 22 06 2019
revised: 02 12 2019
accepted: 16 12 2019
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Recurrent myocardial infarction (MI) is common in patients with coronary artery disease and is associated with high mortality. Long-term reprogramming of myeloid progenitors occurs in response to inflammatory stimuli and alters the organism's response to secondary inflammatory challenges. This study examined the effect of recurrent MI on bone marrow response and cardiac inflammation. The investigators developed a surgical mouse model in which 2 subsequent MIs affected different left ventricular regions in the same mouse. Recurrent MI was induced by ligating the left circumflex artery followed by the left anterior descending coronary artery branch. The study characterized the resulting ischemia by whole-heart fluorescent coronary angiography after optical organ clearing and by cardiac magnetic resonance imaging. A first MI-induced bone marrow "memory" via a circulating signal, reducing hematopoietic maintenance factor expression in bone marrow macrophages. This dampened the organism's reaction to subsequent events. Despite a similar extent of injury according to troponin levels, recurrent MI caused reduced emergency hematopoiesis and less leukocytosis than a first MI. Consequently, fewer leukocytes migrated to the ischemic myocardium. The hematopoietic response to lipopolysaccharide was also mitigated after a previous MI. The increase of white blood count in 28 patients was lower after recurrent MI compared with their first MI. The data suggested that hematopoietic and innate immune responses are shaped by a preceding MI.

Sections du résumé

BACKGROUND
Recurrent myocardial infarction (MI) is common in patients with coronary artery disease and is associated with high mortality. Long-term reprogramming of myeloid progenitors occurs in response to inflammatory stimuli and alters the organism's response to secondary inflammatory challenges.
OBJECTIVES
This study examined the effect of recurrent MI on bone marrow response and cardiac inflammation.
METHODS
The investigators developed a surgical mouse model in which 2 subsequent MIs affected different left ventricular regions in the same mouse. Recurrent MI was induced by ligating the left circumflex artery followed by the left anterior descending coronary artery branch. The study characterized the resulting ischemia by whole-heart fluorescent coronary angiography after optical organ clearing and by cardiac magnetic resonance imaging.
RESULTS
A first MI-induced bone marrow "memory" via a circulating signal, reducing hematopoietic maintenance factor expression in bone marrow macrophages. This dampened the organism's reaction to subsequent events. Despite a similar extent of injury according to troponin levels, recurrent MI caused reduced emergency hematopoiesis and less leukocytosis than a first MI. Consequently, fewer leukocytes migrated to the ischemic myocardium. The hematopoietic response to lipopolysaccharide was also mitigated after a previous MI. The increase of white blood count in 28 patients was lower after recurrent MI compared with their first MI.
CONCLUSIONS
The data suggested that hematopoietic and innate immune responses are shaped by a preceding MI.

Identifiants

pubmed: 32130926
pii: S0735-1097(20)30165-0
doi: 10.1016/j.jacc.2019.12.056
pmc: PMC7254576
mid: NIHMS1569273
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

901-915

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL125428
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL076136
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL131478
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL142494
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL131495
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL139598
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

Elife. 2015 Mar 30;4:e05521
pubmed: 25821987
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):658-70
pubmed: 15662026
Nat Med. 2018 Jun;24(6):711-720
pubmed: 29867229
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Eur J Heart Fail. 2011 Feb;13(2):148-53
pubmed: 21037250
J Exp Med. 2007 Nov 26;204(12):3037-47
pubmed: 18025128
Nature. 2014 Jan 16;505(7483):327-34
pubmed: 24429631
Circulation. 2004 Apr 6;109(13):1594-602
pubmed: 15023878
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
J Mol Cell Cardiol. 1998 Jul;30(7):1443-7
pubmed: 9710811
Cell. 2018 Jan 11;172(1-2):147-161.e12
pubmed: 29328910
JACC Heart Fail. 2014 Apr;2(2):131-7
pubmed: 24720919
Science. 2009 Jul 31;325(5940):612-6
pubmed: 19644120
J Exp Med. 2011 Feb 14;208(2):261-71
pubmed: 21282381
Cell Stem Cell. 2015 May 7;16(5):477-87
pubmed: 25957903
Circ Heart Fail. 2009 May;2(3):217-22
pubmed: 19808343
Circ Cardiovasc Interv. 2014 Aug;7(4):543-51
pubmed: 24939928
Cell. 2015 Jul 16;162(2):246-257
pubmed: 26186186
J Anat. 2008 Jan;212(1):12-8
pubmed: 18067545
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
Cell. 2018 Jan 11;172(1-2):162-175.e14
pubmed: 29328911
Cell. 2014 Apr 24;157(3):726-39
pubmed: 24746791
J Exp Med. 2017 Nov 6;214(11):3293-3310
pubmed: 28978634
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Am J Physiol Heart Circ Physiol. 2018 Apr 01;314(4):H812-H838
pubmed: 29351451
Nature. 2012 Jul 19;487(7407):325-9
pubmed: 22763456
Circulation. 2015 Nov 17;132(20):1880-90
pubmed: 26358260

Auteurs

Sebastian Cremer (S)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Maximilian J Schloss (MJ)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Claudio Vinegoni (C)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Brody H Foy (BH)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts.

Shuang Zhang (S)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

David Rohde (D)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Maarten Hulsmans (M)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Paolo Fumene Feruglio (P)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Stephen Schmidt (S)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Greg Wojtkiewicz (G)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

John M Higgins (JM)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts.

Ralph Weissleder (R)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Filip K Swirski (FK)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Matthias Nahrendorf (M)

Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Department of Internal Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany. Electronic address: mnahrendorf@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH